Company press releases
| Tid | Selskap | Tittel | Sektor | Kategori |
|---|---|---|---|---|
| 13 Apr 2021 19:46 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Protokoll fra generalforsamling | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 09 Apr 2021 08:00 CEST |
SOFTOX SOLUTIONS | SOFTOX SOLUTIONS AS: NATIONAL COMMITTEE ON HEALTH RESEARCH ETHICS APPROVES FIRST-IN-HUMAN CLINICAL STUDY FOR SOFTOX WOUND TREATMENT AGENT FOR CHRONIC WOUNDS, BIOFILM ERADICATOR (SBE) | 20103010 Biotechnology | Non-regulatory press releases |
| 06 Apr 2021 09:00 CEST |
SOFTOX SOLUTIONS | SOFTOX SOLUTIONS AS: NOTICE OF ANNUAL GENERAL MEETING | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Apr 2021 08:45 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Annual Report 2020 | 20103010 Biotechnology | Annual financial and audit Reports |
| 29 Mar 2021 14:32 CEST |
SOFTOX SOLUTIONS | SoftOx Solutions AS: The Swedish Chemicals Agency rejected the application for approval of SoftOx Disinfection Products – requesting more data, - can lead to six months delay | 20103010 Biotechnology | Inside information |
| 23 Mar 2021 15:49 CET |
SOFTOX SOLUTIONS | SOFTOX SOLUTIONS AS HAS COMPLETED ENROLMENT OF SOFTOX WOUND IRRIGATION SOLUTION CONFIRMATORY STUDY (SWIS-02) | 20103010 Biotechnology | Non-regulatory press releases |
| 22 Mar 2021 08:30 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS and the Norwegian Defense Research Establishment (FFI) have entered into a collaboration agreement | 20103010 Biotechnology | Non-regulatory press releases |
| 17 Mar 2021 10:05 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New share capital registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 16 Mar 2021 13:53 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: New share capital registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 15 Mar 2021 08:30 CET |
SOFTOX SOLUTIONS | SOFTOX SOLUTIONS AS: DANISH MEDICINES AGENCY APPROVES FIRST-IN-HUMAN CLINICAL STUDY FOR SOFTOX WOUND TREATMENT AGENT FOR INFECTIONS IN CHRONIC WOUNDS, BIOFILM ERADICATOR (SBE) | 20103010 Biotechnology | Non-regulatory press releases |
| 04 Mar 2021 12:28 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Final result of Subsequent Offering | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 03 Mar 2021 20:00 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Preliminary result of the Subsequent Offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Mar 2021 08:00 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Last day of the subscription period in the Subsequent Offering | 20103010 Biotechnology | Non-regulatory press releases |
| 01 Mar 2021 10:37 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Share issuance to employees | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 25 Feb 2021 18:38 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: The following is reported from primary insider Claus Seeberg | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 24 Feb 2021 20:50 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Share issuance to employees | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 24 Feb 2021 08:30 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: The following is reported from primary insiders of SoftOx Solutions AS | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 16 Feb 2021 14:53 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: National Prospectus registered and commencement of subscription period in the subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Feb 2021 15:17 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS - Information regarding the repair offering | 20103010 Biotechnology | Non-regulatory press releases |
| 09 Feb 2021 08:45 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Fourth Quarter 2020 Results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Feb 2021 08:17 CET |
SOFTOX SOLUTIONS | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 09 Feb 2021 08:17 CET |
SOFTOX SOLUTIONS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Feb 2021 08:30 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS og Forsvarets Forskningsinstitutt (FFI) inngår intensjonsavtale | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 03 Feb 2021 08:30 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS and the Norwegian Defence Research Establishment (FFI) sign letter of intent | 20103010 Biotechnology | Non-regulatory press releases |
| 02 Feb 2021 20:25 CET |
SOFTOX SOLUTIONS | SoftOx Solutions AS: Exercise of share options and share capital increase | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 15 Jan 2021 11:25 CET |
SoftOx Solutions | SoftOx Solutions AS: New share capital registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 04 Jan 2021 13:55 CET |
SoftOx Solutions | SoftOx Solutions AS: Protokoll fra ekstraordinær generalforsamling | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 04 Jan 2021 12:06 CET |
SoftOx Solutions | SoftOx Solutions AS: Følgende rapporteres fra Primærinnsider Harefrøken Invest AS (Investeringsselskap eid av Helene Ihlen, CEO Geir Almås samboer) – tildelingen er ubetinget | 20103010 Biotechnology | Meldepliktig handel for primærinnsidere |
| 04 Jan 2021 12:06 CET |
SoftOx Solutions | SoftOx Solutions AS: The following is reported from Primary Insider Harefrøken Invest AS (Investment company owned by Helene Ihlen, partner of CEO Geir Almås) - the award is unconditional | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 28 Dec 2020 17:14 CET |
SoftOx Solutions | SoftOx Solutions AS: Innkalling til ekstraordinær generalforsamling | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 28 Dec 2020 17:14 CET |
SoftOx Solutions | SoftOx Solutions AS: Notice of extraordinary general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Dec 2020 12:10 CET |
SoftOx Solutions | SoftOx Solutions AS: New share capital registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 24 Dec 2020 12:10 CET |
SoftOx Solutions | SoftOx Solutions AS: Ny aksjekapital registrert | 20103010 Biotechnology | Kapital- og stemmerettsendringer |
| 21 Dec 2020 10:54 CET |
SoftOx Solutions | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Dec 2020 10:54 CET |
SoftOx Solutions | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 21 Dec 2020 10:25 CET |
SoftOx Solutions | SoftOx Solutions AS melder om ny distribusjonskanal | 20103010 Biotechnology | Innsideinformasjon |
| 21 Dec 2020 10:25 CET |
SoftOx Solutions | SoftOx Solutions AS announces new distribution agreement | 20103010 Biotechnology | Inside information |
| 20 Dec 2020 21:07 CET |
SoftOx Solutions | SoftOx Solutions AS: Følgende rapporteres fra Primærinnsider Harefrøken Invest AS (Investeringsselskap eid av Helene Ihlen, CEO Geir Almås samboer) | 20103010 Biotechnology | Meldepliktig handel for primærinnsidere |
| 20 Dec 2020 21:07 CET |
SoftOx Solutions | SoftOx Solutions AS: The following is reported from Primary Insider Harefrøken Invest AS (Investment company owned by Helene Ihlen, partner of CEO Geir Almås) | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 18 Dec 2020 09:53 CET |
SoftOx Solutions | SoftOx Solutions AS: Hentet NOK 50 millioner etter børs onsdag 16.12 – Mer enn 100% overtegnet | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 18 Dec 2020 09:53 CET |
SoftOx Solutions | SoftOx Solutions AS: Raised NOK 50 million after stock exchange closing Wednesday December 16th - More than 100% oversubscribed | 20103010 Biotechnology | Non-regulatory press releases |
| 16 Dec 2020 23:29 CET |
SoftOx Solutions | SoftOx Solutions AS: Key information relating to the repair issue to be carried out by SoftOx Solutions AS | 20103010 Biotechnology | Ex Date |
| 16 Dec 2020 23:21 CET |
SoftOx Solutions | SoftOx Solutions AS: Private placement successfully completed | 20103010 Biotechnology | Inside information |
| 16 Dec 2020 16:30 CET |
SoftOx Solutions | SoftOx Solutions AS: Contemplated private placement | 20103010 Biotechnology | Inside information |
| 16 Dec 2020 09:35 CET |
SoftOx Solutions | Københavns Universitet og SoftOx Solutions rapporterer om positive resultater med SoftOx Inhalation Solution (SIS) | 20103010 Biotechnology | Innsideinformasjon |
| 16 Dec 2020 09:35 CET |
SoftOx Solutions | University of Copenhagen and SoftOx Solutions reports on positive results on SoftOx Inhalation Solution (SIS) | 20103010 Biotechnology | Inside information |
| 16 Dec 2020 09:00 CET |
SoftOx Solutions | SoftOx announces co-operation with new distributor | 20103010 Biotechnology | Non-regulatory press releases |
| 16 Dec 2020 09:00 CET |
SoftOx Solutions | SoftOx melder om ny distribusjonskanal | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |
| 15 Dec 2020 22:27 CET |
SoftOx Solutions | SoftOx Solutions Q3 Presentation | 20103010 Biotechnology | Non-regulatory press releases |
| 15 Dec 2020 22:27 CET |
SoftOx Solutions | SoftOx Solutions Q3 Presentasjon | 20103010 Biotechnology | Ikke-informasjonspliktige pressemeldinger |